Idiopathic intracranial hypertension (IIH) is characterized by elevation of intracranial pressure (ICP) without; an identifiable cause. Over the years, a number of varied treatments have been suggested with the; ultimate goals to preserve vision and alleviate symptoms, especially headache. There are currently no; established guidelines to standardize the treatment of IIH. In 2015, the Cochrane review concluded that; there is insufficient evidence on the best therapeutic strategies. Traditionally, the treatment of IIH has; included weight loss, medications, and surgical interventions when rapid or progressive vision loss occurs; despite optimal medical therapy.
Date
2021-02
Language
eng
Format
video/mp4
Type
Image/MovingImage
Source
2021 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of
NANOS Annual Meeting 2021: Journal Club: What You Need to Know Now!
